Cytomegalovirus induces sialyl Lewis(X) and lewis(x) on human endothelial cells

Transplantation

Volumn 69, Issue 6, 2000, Pages 1202-1209

  Cebulla, Colleen M ^a   Miller, Daniel M ^a   Knight, Deborah A ^a   Briggs, Bruce R ^a   McGaughy, Viy ^a   Sedmak, Daniel D ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b 129 Hamilton Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUCOSYLTRANSFERASE; GLYCOSYLTRANSFERASE; SIALIC ACID DERIVATIVE; SIALYLTRANSFERASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; HISTOCOMPATIBILITY; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RECIPIENT; VASCULAR DISEASE; VIRUS INACTIVATION; VIRUS INDUCTION;

EID: 0034719870     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200003270-00027     Document Type: Article

References (74)

1. Britt WJ. Infections associated with human cytomegalovirus. In: Glaser R, Jones JE, eds. Herpesvirus infections. New York: Marcel Dekker, 1994: 59.
2. Wong YW, Warner NE. Cytomegalic inclusion disease in adults. Arch Pathol 1962; 74: 403.
3. Percivalle E, Revello MG, Vago L, Morini F, Gerna G. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J Clin Invest 1993; 92: 663.
4. Sinzger C, Grefte A, Plachter B, Gouw ASH, The TH, Jahn G. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 1995; 76: 741.
5. Theise ND, Conn M, Thung SN. Localization of cytomegalovirus antigens in liver allografts over time. Human Pathol 1993; 24: 103.
6. Yonemitsu Y, Nakagawa K, Tanaka S, Mori R, Sugimachi K, Sueishi K. In situ detection of frequent and active infection of human cytomegalovirus in inflammatory abdominal aortic aneurysms: possible pathogenic role in sustained chronic inflammatory reaction. Lab Invest 1996; 74: 723.
7. Baskar JF, Smith PP, Ciment GS, et al. Developmental analysis of the cytomegalovirus enhancer in transgenic animals. J Virol 1996; 70: 3215.
8. Koffron AJ, Hummel M, Patterson BK, et al. Cellular localization of latent murine cytomegalovirus. J Virol 1998; 72(1): 95.
9. Fish KN, Soderberg-Naucler C, Mills LK, Stenglein S, Nelson JA. Human cytomegalovirus persistently infects aortic endothelial cells. J Virol 1998; 72(7): 5661.
10. Waldman WJ, Knight DA, Huang EH, Sedmak DD. Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: an in vitro model. J Infect Dis 1995; 171: 263.
11. Grundy JE, Lawson KM, MacCormac LP, Fletcher JM, Yong KL. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial contact and during neutrophil transendothelial migration. J Infect Dis 1998; 177(6): 1465.
12. Revello MG, Percivalle E, Arbustini E, Pardi R, Sozzani S, Gerna G. In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia. J Clin Invest 1998; 101: 2686.
13. Rowe WP, Hartley JW, Waterman S, Turner HC, Huebner RJ. Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc Soc Exp Biol Med 1956; 92: 418.
14. Weller TH. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. N Engl J Med 1971; 285: 203.
15. Gerna G, Zipeto D, Percivalle E, et al. Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients. J Infect Dis 1992; 166: 1236.
16. Bitsch A, Kirchner H, Dupke R, Bein G. Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse transcription-polymerase chain reaction. J Infect Dis 1993; 167: 740.
17. Taylor-Weideman J, Sissons JGP, Borysiewics LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 1991; 72: 2059.
18. Lang DJ, Ebert PA, Rodgers BM, Boggess HP, Rixse RS. Reduction of postperfusion cytomegalovirus-infections following the use of leukocyte depleted blood. Transfusion 1977; 17(4): 391.
19. Tolkoff-Rubin NE, Rubin RH, Keller EE, Baker GP, Stewart JA, Hirsch MS. Cytomegalovirus infection in dialysis patients and personnel. Ann Intern Med 1978; 89: 625.
20. Gilbert GL, Hayes K, Hudson IL, James J. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Lancet 1989; 1: 1228.
21. de Gaan-Hentzen YCE, Gratama JW, Mudde GC, et al. Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion 1989; 29: 757.
22. van Prooijen HC, Visser JJ, van Oostendorp WR, De Gast GC, Verdonck LF. Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high affinity filters. Br J Haematol 1994; 87: 144.
23. Spector SA, Merrill R, Wolf D, Dankner WM. Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol 1992; 30: 2359.
24. Grundy JE, Downes KL. Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus. Immunology 1993; 78: 405.
25. Grundy JE, Pahal GC, Akbar AN. Increased adherence of CD2 peripheral blood lymphocytes to cytomegalovirus-infected fibroblasts is blocked by anti-LFA-3 antibody. Immunology 1993; 78: 413.
26. Sedmak DD, Knight DA, Vook NC, Waldman WJ. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus infected endothelial cells. Transplantation 1994; 58: 1379.
27. Shahgasempour S, Woodroffe SB, Garnett HM. Alterations in the expression of ELAM-1, ICAM-1 and VCAM-1 after in vitro infection of endothelial cells with a clinical isolate of human cytomegalovirus. Microbiol Immunol 1997; 41(2): 121.
28. Leong CC, Chapman TL, Bjorkman PJ, et al. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med 1998; 187(May 18): 1681.
29. Rosen SD, Bertozzi CR. The selectins and their ligands. Curr Opin Cell Biol 1994; 6: 663.
30. Kansas GS. Selectins and their ligands: current concepts and controversies. Blood 1996; 88(9): 3259.
31. von Andrian UH, Chambers JD, Berg EL, et al. L-selectin mediates neutrophil rolling in inflamed venules through sialyl Lewis X-dependent and -independent recognition pathways. Blood 1993; 82: 182.
32. Polly MJ, Phillips ML, Wayner E, et al. CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. Proc Natl Acad Sci USA 1991; 88: 6224.
33. Varki A. Selectin ligands. Proc Natl Acad Sci USA 1994; 91: 7390.
34. x and related structures as adhesion molecules. Histochem J 1992; 24: 771.
35. Vaccaro PS, Joseph LB, Titterington L, Stephens RE. Methods for the initiation and maintenance of human endothelial cell culture. Vase Surg 1987; 21: 391.
36. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745.
37. Gimbrone MA Jr, Cotran RS, Folkman J. Human vascular endothelial cells in culture: growth and DNA synthesis. J Cell Biol 1974; 60: 673.
38. Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R. An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci USA 1979; 76: 5674.
39. Waldman WJ, Sneddon JM, Stephens RE, Roberts WH. Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells. J Med Virol 1989; 28: 223.
40. Waldman WJ, Roberts WH, Davis DH, Williams MV, Sedmak DD, Stephens RE. Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells. Arch Virol 1991; 117: 143.
41. de Vries T, van den Eijnden DH. Occurrence and specificities of the a3-fucosyltransferases. Histochem J 1992; 24: 761.
42. Kukowska-Latallo JF, Larsen RD, Nair RP, Lowe JB. A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group alpha(1,3/1,4)fucosyltransferase. Genes Dev 1990; 4(8): 1288.
43. Sasaki K, Watanabe E, Kawashima K, et al. Expression cloning of a novel Galb(1-3/1-4)GlcNAc a2,3-sialyltransferase using lectin resistance selection. J Biol Chem 1993; 268(30): 22782.
44. Cameron HS, Szczepaniak D, Weston BW. Expression of human chromosome 19p a(1,3)-fucosyltransferase genes in normal tissues. J Biol Chem 1995; 270(34): 20112.
45. Lowe JB, Kukowska-Latallo JF, Nair RP, et al. Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis x and VIM-2 epitopes but not ELAM-1-dependent cell adhesion. J Biol Chem 1991; 266(26): 17467.
46. Natsuka S, Gersten KM, Zenita K, Kannagi R, Lowe JB. Molecular cloning of a cDNA encoding a novel human leukocyte a-1,3-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant. J Biol Chem 1994; 269(24): 16789.
47. Majuri M-L, Pinola M, Niemela R, et al. Alpha 2,3,-sialyl and alpha 1,3-fucosyltransferase-dependent synthesis of sialyl Lewis x, an essential oligosaccharide present on L-selectin counterreceptors, in cultured endothelial cells. Eur J Immunol 1996; 24: 3205.
48. Ghazal P, Nelson JA. Transcription factors and viral regulatory proteins as potential mediators of human cytomegalovirus pathogenesis. In: Becker Y, Darai G, Huang E-S, eds. Molecular aspects of human cytomegalovirus diseases. New York: Springer-Verlag, 1993: 360.
49. Hagemeier C, Walker SW, Sissons PJG, Sinclair JH. The 72K IE1 and 80K IE2 proteins of human cytomegalovirus independently trans-activate the c-fos, c-myc, and hsp70 promoters via basal promoter elements. J Gen Virol 1992; 73: 2385.
50. Liu B, Stinski MF. Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J Virol 1992; 66(7): 4434.
51. Burns L, Pooley J, Vercellotti G. Intercellular adhesion molecule-1 (ICAM-1) expression is directly activated by cytomegalovirus immediate early proteins in human endothelium. Blood 1997; 90(10): 567a.
52. Spertini O, Luscinskas FW, Kansas GS, et al. Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol 1991; 147: 2565.
53. Turunen JP, Paavonen T, Majuri ML, et al. Sialyl lewis x- and L-selectin-dependent site-specific lymphocyte extravasation into renal transplants during acute rejection. Eur J Immunol 1994; 24: 1130.
54. x as a new tumor-associated antigen. Can Res 1984; 44: 5279.
55. Feizi T. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature 1985; 314: 53.
56. Walz G, Aruffo A, Kolanus W, Bevilacqua M, Seed B. Recognition by ELAM-1 of sialyl-leX determinant on myeloid and tumor cells. Science 1990; 250: 1132.
57. Takada A, Ohmori K, Yoneda T, et al. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 1992; 55: 354.
58. Aruffo A, Dietsch MT, Wan H, Hellstrom KE, Hellstrom I. Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines. Proc Natl Acad Sci USA 1992; 89: 2292.
59. Stone JP, Wagner DD. P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest 1993; 92: 804.
60. Grefte JMM, van der Giessen M, van Son WJ, The TH. Circulating cytomegalovirus infected endothelial cells in patients with an active cytomegalovirus infection. J Infect Dis 1993; 167: 270.
61. Grefte JMM, Blom N, van der Giessen M, van Son WJ, The TH. Ultrastructural analysis of circulation cytomegalic cells in patients with active cytomegalovirus infection: evidence for virus production and endothelial origin. J Infect Dis 1993; 168: 1110.
62. Salzberger B, Myerson D, Boeckh M. Circulating cytomegalovirus (CMV)-infected endothelial cells in marrow transplant patients with CMV disease and CMV infection. J Infect Dis 1997; 176: 778.
63. Paya CV, Hermans PE, Wiesner RH, et al. Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthoptic liver transplantations. J Infect Dis 1989; 160: 752.
64. Waldman WJ, Knight DA, Huang EH. An in vitro model of T cell activation by autologous cytomegalovirus (CMV)-infected human adult endothelial cells: contribution of CMV-enhanced endothelial ICAM-1. J Immunol 1998; 160: 3143.
65. Muldoon J, O'Riordan K, Rao S, Abecassis M. Ischemic colitis secondary to venous thrombosis: a rare presentation of cytomegalovirus vasculitis following renal transplantation. Transplantation 1995; 61: 1651.
66. x oligosaccharide. J Cell Biol 1992; 117: 895.
67. Lowe JB, Stoolman LM, Nair RP, Larsen RD, Berhend TL, Marks RM. ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA. Cell 1996; 63(3): 475.
68. Waldman WJ, Adams PW, Orosz CG, Sedmak DD. T lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells. Transplantation 1992; 54: 887.
69. Warren HS, Altin JG, Waldron JC, Kinnear BF, Parish CR. A carbohydrate structure associated with CD15 (Lewis x) on myeloid cells is a novel ligand for, human CD2. J Immunol 1996; 156: 2866.
70. Buerke M, Weyrich AS, Zheng Z, Gaeta FCA, Forrest MJ, Lefer AM. Sialyl-Lewis x-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J Clin Invest 1994; 93: 1140.
71. Han KT, Sharar SR, Phillips ML, Harlan JM, Winn RK. Sialyl Lewis x oligosaccharide rescues ischemia-reperfusion injury in the rabbit ear. J Immunol 1995; 155: 4011.
72. Tedder TF, Steeber DA, Chen A, Engel P. The selectins: vascular adhesion molecules. FASEB J 1995; 9: 866.
73. O'Connell D, Koenig A, Jennings S, et al. Calcium-dependent oligonucleotide antagonists specific for L-selectin. Proc Natl Acad Sci USA 1996; 93: 5883.
74. x inhibit selectin-mediated cell adhesion. J Biol Chem 1997; 272(41): 25608.